Molecular genetic and epigenetic analysis of NCX2/SLC8A2 at 19q13.3 in human gliomas

Neuropathology and Applied Neurobiology
M QuM Nistér

Abstract

Loss of heterozygosity at 19q13.3 is a common genetic change in human gliomas, indicating yet unknown glial-specific tumour suppressor genes in this chromosome region. NCX2/SLC8A2 located on chromosome 19q13.32 encodes a Na(+)/Ca(2+) exchanger, which contributes to intracellular Ca(2+) homeostasis. Its expression is restricted to brain, and it is present neither in other normal tissues nor in gliomas at any significant level. The aim of this study was to investigate if NCX2 might be a tumour suppressor gene involved in glioma. We performed a systematic analysis of NCX2 in 42 human gliomas using microsatellite analysis for evaluation of loss of heterozygosity at 19q, DNA sequencing and DNA methylation analysis. Except for three known intragenic single nucleotide polymorphisms, rs12459087, rs7259674 and rs8104926, no NCX2 sequence variations were detected in any of the tumour samples. Furthermore, a CpG island in the 5' promoter region of NCX2 was unmethylated. Interestingly, the CpG sites of three gene-body CpG islands located in exon 2, intron 2-3 and exon 3 and of a 5' CpG-rich area relevant to so-called CpG island shore of NCX2 were methylated in all eight glioma samples and in three established glioma cell lines tested. Surp...Continue Reading

References

Nov 11, 1998·Cancer Genetics and Cytogenetics·C WongM S Piver
Nov 7, 1999·The American Journal of Pathology·C WilliamsJ Lundeberg
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S SmithR B Jenkins
Jun 13, 2000·Journal of Neuropathology and Experimental Neurology·M NakamuraH Ohgaki
Jun 13, 2000·Journal of Neuropathology and Experimental Neurology·A von DeimlingK von Ammon
Jun 9, 2001·Molecular Carcinogenesis·S MaegawaM Oshimura
Oct 5, 2001·Journal of the National Cancer Institute·C NguyenP A Jones
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Jul 12, 2002·Annals of Neurology·Marc SansonKhê Hoang-Xuan
Feb 13, 2003·Journal of Neuropathology and Experimental Neurology·Guido Reifenberger, David N Louis
May 8, 2003·Pflügers Archiv : European journal of physiology·Beate D QuednauKenneth D Philipson
Jul 3, 2003·Nature Reviews. Molecular Cell Biology·Michael J BerridgeH Llewelyn Roderick
Aug 2, 2003·Annals of Neurology·Christian HartmannAndreas von Deimling
Dec 17, 2004·Pharmacological Reviews·L AnnunziatoG F Di Renzo
Feb 1, 2005·The Journal of Molecular Diagnostics : JMD·Mansour AkbariHans E Krokan
Dec 22, 2005·Nature Reviews. Genetics·Andrew P FeinbergSteven Henikoff
Jan 25, 2006·International Journal of Cancer. Journal International Du Cancer·Marica EoliGaetano Finocchiaro
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Intergroup Radiation Therapy Oncology Group Trial 9402Walter Curran
Oct 6, 2006·Journal of Neuropathology and Experimental Neurology·Constance A GriffinKathleen M Murphy
Oct 13, 2006·Acta Neuropathologica·Mingqi QuZhi-Ping Ren
Jun 23, 2007·Nature Reviews. Cancer·Gregory R MonteithSarah J Roberts-Thomson
Jul 6, 2007·Brain Pathology·Annegret KunitzChristian Hartmann
Sep 26, 2007·Human Molecular Genetics·Manel Esteller
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Aug 25, 2007·The Biochemical Journal·Jonathan Lytton
Oct 6, 2007·Journal of Neuropathology and Experimental Neurology·Zhi-Ping RenMonica Nistér
Feb 28, 2008·International Journal of Cancer. Journal International Du Cancer·Markus J RiemenschneiderGuido Reifenberger
May 9, 2008·Nature Reviews. Genetics·Miho M Suzuki, Adrian Bird
Nov 7, 2008·Methods in Molecular Biology·Paul Cairns
Mar 31, 2009·Nature Biotechnology·Madeleine P BallGeorge M Church

❮ Previous
Next ❯

Citations

Aug 24, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Liu YangJian Li
Oct 2, 2015·Disease Markers·Liu YangMei Liu
Jun 28, 2019·Clinical Pharmacology and Therapeutics·Cong HuaiShengying Qin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.